We are happy to announce the publication of two high impact manuscripts, one that highlights an innovative new approach to predict causal variants of autoimmunity by mapping epigenomic modifications in the context of a three-dimensional genome, and one that highlights our ongoing mission to use whole exome sequencing to identify rare genetic mutations that cause human diseases.
Pelikan, et al. Nat Comm 2018: https://www.nature.com/articles/s41467-018-05328-9
Kondo, et al. JCI Insight 2018: https://www.ncbi.nlm.nih.gov/pubmed/30046013